Valuation: EMVision Medical Devices Ltd

Market Cap 139M 95.58M 83.92M 77.24M 71.98M 136M 9.09B 929M 360M 4.46B 359M 351M 15.52B P/E 2026 *
-15.2x
P/E 2027 * -13.2x
Enterprise Value 139M 95.58M 83.92M 77.24M 71.98M 136M 9.09B 929M 360M 4.46B 359M 351M 15.52B EV / Sales 2026 *
25.2x
EV / Sales 2027 * 27.7x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 day-1.65%
1 week-4.49%
Current month-1.65%
1 month-13.37%
3 months-5.70%
6 months-16.29%
Current year-16.29%
1 week 1.47
Extreme 1.47
1.55
1 month 1.47
Extreme 1.47
1.75
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.13
Extreme 1.13
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Director/Board Member 80 29/09/2020
Director/Board Member - 05/06/2025
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
04-23Buy

Director

10,000 0.0108%
01-02Expiration

Chairman

300,000 0.3228%
11-18Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-4.49%-14.37%+27.35% 97.42M
+2.39%+4.29%+21.80%-1.11% 186B
+1.18%+0.14%-25.21%+19.75% 141B
+1.70%+2.57%-3.67%-18.20% 135B
+0.89%-3.15%-58.90%-19.57% 63.44B
+1.69%+2.60%+19.19%+0.55% 52.09B
+0.82%-0.12%-26.73%-33.51% 43.6B
+0.42%+1.34%+10.74%+11.79% 37.52B
+0.82%+2.42%+5.91%+42.81% 36.82B
+1.33%-0.03%-14.60%-19.62% 29.12B
Average +0.92%+2.02%-8.58%+1.02% 72.46B
Weighted average by Cap. +1.50%+3.86%-5.10%-1.52%

Financials

2026 *2027 *
Net sales 5.5M 3.8M 3.33M 3.07M 2.86M 5.39M 361M 36.89M 14.29M 177M 14.25M 13.94M 616M 5M 3.45M 3.03M 2.79M 2.6M 4.9M 328M 33.54M 12.99M 161M 12.96M 12.68M 560M
Net income -9.1M -6.28M -5.51M -5.08M -4.73M -8.92M -597M -61.04M -23.65M -293M -23.58M -23.07M -1.02B -12M -8.28M -7.27M -6.69M -6.24M -11.76M -787M -80.49M -31.19M -386M -31.09M -30.42M -1.34B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
01/07/26 A$1.490 -1.65% 25,475
30/06/26 A$1.515 +0.66% 131,705
29/06/26 A$1.505 -0.66% 23,280
26/06/26 A$1.515 +2.36% 19,737
25/06/26 A$1.480 -2.95% 83,676
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.490AUD
Average target price
3.150AUD
Spread / Average Target
+111.41%

Annual profits - Rate of surprise